» Authors » Joseph C Cleveland Jr

Joseph C Cleveland Jr

Explore the profile of Joseph C Cleveland Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 169
Citations 8109
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sayer G, Ahmed M, Mehra M, Gosev I, Vidula H, DeVore A, et al.
J Card Fail . 2025 Jan; PMID: 39855458
Background: The benefit of implantable cardioverter-defibrillators (ICDs) and cardiovascular resynchronization therapy defibrillators (CRT-Ds) in patients supported with a HeartMate 3 left ventricular assist device (LVAD) remains uncertain. Methods: An analysis...
2.
Murphy R, Park S, Allen L, Ambardekar A, Cleveland Jr J, Cain M, et al.
JACC Adv . 2025 Jan; 4(1):101449. PMID: 39759431
Background: Currently, there is no mathematical model used nationally to determine the medical urgency of patients on the heart transplant waitlist in the United States. While the current organ distribution...
3.
Cain M, Firstenberg M, Cleveland Jr J
US Cardiol . 2024 Dec; 15:e16. PMID: 39720485
For nearly 60 years, there have been two surgical treatment options for individuals with severe advanced heart failure: heart transplantation or implantation of a left ventricular assist device. As these...
4.
Molina E, Ahmed M, Sheikh F, Cleveland Jr J, Goldstein D, Uriel N, et al.
JACC Heart Fail . 2024 Dec; PMID: 39708027
Background: Prior analyses have suggested that a smaller left ventricular end-diastolic diameter (LVEDD) is associated with reduced survival following HeartMate 3 left ventricular assist device implantation. Objectives: In this trial-based...
5.
Shah P, Sayer G, Sinha S, Kanwar M, Cowger J, Pagani F, et al.
JACC Heart Fail . 2024 Jul; 12(11):1898-1912. PMID: 39066758
Background: Hemocompatibility-related adverse events affect patients after left ventricular assist device (LVAD) implantation but are hard to predict. Objectives: Dynamic risk modeling with a multistate model can predict risk of...
6.
Cleveland Jr J, Cain M
JACC Adv . 2024 Jun; 3(4):100911. PMID: 38939667
No abstract available.
7.
Cleveland Jr J
J Thorac Cardiovasc Surg . 2024 Mar; 168(1):163-164. PMID: 38521492
No abstract available.
8.
Bakhtiyar S, Maksimuk T, Gutowski J, Park S, Cain M, Rove J, et al.
Am J Transplant . 2024 Mar; 24(10):1803-1815. PMID: 38521350
Donation after circulatory death (DCD) could account for the largest expansion of the donor allograft pool in the contemporary era. However, the organ yield and associated costs of normothermic regional...
9.
Cain M, Park S, Schafer M, Hay-Arthur E, Justison G, Zhan Q, et al.
JTCVS Tech . 2023 Dec; 22:350-358. PMID: 38152164
Objective: Donation after circulatory death (DCD) procurement and transplantation after thoracoabdominal normothermic regional perfusion (TA-NRP) remains a novel technique to improve cardiac and hepatic allograft preservation but may be complicated...
10.
Suarez-Pierre A, Iguidbashian J, Kirsch M, Cain M, Aftab M, Reece T, et al.
J Cardiovasc Med (Hagerstown) . 2023 Dec; 25(2):158-164. PMID: 38149702
Aims: There is wide variability in the practice of cardiac preservation for heart transplantation. Prior reports suggest that the type of solution may be linked with a reduced incidence of...